Opus Genetics, Inc. Stockholders' Equity Attributable to Noncontrolling Interest
Opus Genetics, Inc. (IRD) had Stockholders' Equity Attributable to Noncontrolling Interest of $10.71 million as of 2011-12-31, per its 10-K filed 2012-03-16.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2012-03-16
- 2011-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $10.71M.
- 2010-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $10.40M.
- 2009-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $4.90M.
- 2008-12-31: Stockholders' Equity Attributable to Noncontrolling Interest -$2.60M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest |
|---|---|
| 2011-12-31 | $10.71M 10-K · filed 2012-03-16 |
| 2010-12-31 | $10.40M 10-K · filed 2012-03-16 |
| 2009-12-31 | $4.90M 10-K · filed 2012-03-16 |
| 2008-12-31 | -$2.60M 10-K · filed 2012-03-16 |
| 2007-12-31 | $958.19K 10-K · filed 2012-03-16 |
| 2006-12-31 | $3.21M 10-K · filed 2012-03-16 |
| 2005-12-31 | $4.83M 10-K · filed 2012-03-16 |
| 2004-12-31 | -$564.17K 10-K · filed 2012-03-16 |
| 2003-12-31 | $2.48M 10-K · filed 2012-03-16 |
| 2002-12-31 | $2.71M 10-K · filed 2012-03-16 |
| 2001-12-31 | $3.89M 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |